Recently, a CEO I know (I’ll call him Jeff) invited me to weigh in on a corporate strategy initiative that his company was undertaking. Jeff and his leadership team had been focused on day-to-day ...

By Matthew Harrington, Global Head, Clinical Product, Syneos Health | Artificial intelligence (AI) now features prominently in boardroom and executive discussions across the life sciences industry.

in investment strategies deserves critical examination. Investors should question what financial institutions are doing and what kinds of risks they truly believe in. Many individuals may not fully ...